emicizumab

Spain

Drugs containing this active substance

  • HEMLIBRA 150 MG/ML SOLUTION FOR INJECTION

    It is used to treat patients of all ages with hemophilia A (congenital factor VIII deficiency), both in those who have developed factor VIII inhibitors and those who have not (in cases of severe or moderate disease with a severe bleeding phenotype). The medication helps to prevent or reduce bleeding episodes.

    Form: solution for injection

    Active substance Dosage
    emicizumab 150 mg

    ATC: B02B B02BX B02BX06

    Manufacturer: Roche Registration Gmbh

  • HEMLIBRA 30 MG/ML SOLUTION FOR INJECTION

    It is used to treat patients of all ages with hemophilia A (congenital factor VIII deficiency), both in those who have developed factor VIII inhibitors and those who have not (in cases of severe or moderate disease with a severe bleeding phenotype). It helps to prevent or reduce bleeding episodes.

    Form: solution for injection

    Active substance Dosage
    emicizumab 30 mg

    ATC: B02B B02BX B02BX06

    Manufacturer: Roche Registration Gmbh